Samuel Isaly’s Orbimed Advisors Sells Some Intercept Pharmaceuticals Stock at $62.50/Share
Orbimed Advisors, Intercept Pharmaceuticals: Samuel Isaly and his hedge fund, Orbimed Advisors, is focused on healthcare stocks.
Posts Tagged ‘Samuel Isaly’
Orbimed Downgrades its Position in Intercept Pharmaceuticals
Orbimed Advisors, Intercept Pharmaceuticals: In a recent SEC filing, Samuel Isaly and his hedge fund, Orbimed Advisors, reported decreasing their holding in Intercept Pharmaceuticals...
Should You Buy Fluidigm Corporation (FLDM)?
Now, according to many market players, hedge funds are assumed to be overrated, old investment vehicles of an era lost to time.
Is Pacira Pharmaceuticals Inc (PCRX) Going to Burn These Hedge Funds?
To the average investor, there are many methods market participants can use to analyze publicly traded companies.
Hedge Funds Are Crazy About Astex Pharmaceuticals, Inc. (ASTX)
In the 21st century investor’s toolkit, there are dozens of indicators shareholders can use to analyze publicly traded companies.
Should You Avoid Insulet Corporation (PODD)?
To many of your peers, hedge funds are assumed to be delayed, outdated financial tools of a period lost to current times.
Do Hedge Funds and Insiders Love Seattle Genetics, Inc. (SGEN)?
At the moment, there are a multitude of metrics shareholders can use to monitor stocks. A pair of the most useful are hedge fund and insider trading sentiment.
Hedge Funds Aren’t Crazy About Vocera Communications Inc (VCRA) Anymore
In today’s marketplace, there are a multitude of gauges shareholders can use to monitor their holdings.
Hedge Fund Bets On Onyx Pharmaceuticals, Inc. (ONXX)
As fast as we can type this, Phill Gross and Robert Atchinson's hedge fund, Adage Capital Partners, disclosed ownership of about 3.7 million shares of Onyx Pharmaceuticals, ...
Here is What Hedge Funds Think About Dynavax Technologies Corporation (DVAX)
If you were to ask many market players, hedge funds are seen as useless, outdated financial vehicles of a forgotten age.
Hedge Funds Are Dumping Dendreon Corporation (DNDN)
To the average investor, there are tons of methods shareholders can use to monitor the equity markets.
Hedge Funds Are Buying ACADIA Pharmaceuticals Inc. (ACAD)
In the eyes of many of your fellow readers, hedge funds are viewed as overrated, outdated financial tools of a forgotten age.
This Metric Says You Are Smart to Buy Neurocrine Biosciences, Inc. (NBIX)
In the financial world, there are dozens of indicators investors can use to track publicly traded companies. Two of the best are hedge fund and insider trading movement.
Here is What Hedge Funds Think About Syneron Medical Ltd. (ELOS)
Now, according to many investors, hedge funds are viewed as delayed, outdated investment tools of an era lost to time.
Is XenoPort, Inc. (XNPT) Going to Burn These Hedge Funds?
At the moment, there are plenty of metrics market participants can use to monitor the equity markets.
What Hedge Funds Think About ArQule, Inc. (ARQL)
In the 21st century investor’s toolkit, there are many metrics shareholders can use to monitor stocks.
Hedge Funds Are Buying Impax Laboratories Inc (IPXL)
At the moment, there are tons of indicators shareholders can use to analyze publicly traded companies.
Hi-Tech Pharmacal Co. (HITK): Hedge Funds Aren’t Crazy About It, Insider Sentiment Unchanged
To the average investor, there are tons of gauges investors can use to monitor stocks. A duo of the best are hedge fund and insider trading activity.
Here is What Hedge Funds and Insiders Think About Puma Biotechnology Inc (PBYI)
In today’s marketplace, there are dozens of methods market participants can use to watch the equity markets.
Is Align Technology, Inc. (ALGN) Going to Burn These Hedge Funds?
To the average investor, there are many gauges shareholders can use to analyze the equity markets. Some of the most innovative are hedge fund and insider trading activity.
Do Hedge Funds and Insiders Love Sequenom, Inc. (SQNM)?
If you were to ask many traders, hedge funds are seen as useless, outdated investment vehicles of a period lost to current times.
QLT Inc. (USA) (QLTI): Are Hedge Funds Right About This Stock?
In the financial world, there are many indicators shareholders can use to analyze Mr. Market. A pair of the most innovative are hedge fund and insider trading activity.
AbbVie Inc (ABBV): Are Hedge Funds Right About This Stock?
Now, according to many investors, hedge funds are seen as overrated, outdated investment tools of a period lost to current times.
Incyte Corporation (INCY): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?
In the 21st century investor’s toolkit, there are many gauges shareholders can use to track their holdings.
Natus Medical Inc (BABY): Are Hedge Funds Right About This Stock?
If you were to ask many of your fellow readers, hedge funds are seen as useless, outdated financial vehicles of a period lost to current times.
Array Biopharma Inc (ARRY): Hedge Funds Are Bearish and Insiders Are Undecided, What Should You Do?
At the moment, there are many methods investors can use to analyze Mr. Market. Some of the most innovative are hedge fund and insider trading sentiment.
NxStage Medical, Inc. (NXTM): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?
To many of your peers, hedge funds are perceived as overrated, old investment tools of a period lost to current times.
Should You Buy Regeneron Pharmaceuticals Inc (REGN)?
If you were to ask many investors, hedge funds are viewed as delayed, outdated investment vehicles of an era lost to time.
Should You Avoid Molina Healthcare, Inc. (MOH)?
To the average investor, there are dozens of methods shareholders can use to analyze publicly traded companies.
What Hedge Funds Think About Infinity Pharmaceuticals Inc. (INFI)
In the financial world, there are many methods shareholders can use to track stocks. A couple of the most innovative are hedge fund and insider trading activity.
Onyx Pharmaceuticals, Inc. (ONXX) Investors: Listen Up
In the 21st century investor’s toolkit, there are tons of metrics shareholders can use to track publicly traded companies.
Hedge Funds Are Crazy About BioMarin Pharmaceutical Inc. (BMRN)
In the financial world, there are dozens of gauges shareholders can use to analyze stocks. Two of the most under-the-radar are hedge fund and insider trading sentiment.
This Metric Says You Are Smart to Sell Centene Corp (CNC)
Now, according to many market players, hedge funds are assumed to be delayed, outdated investment vehicles of an era lost to time.
Hedge Funds Are Crazy About WellCare Health Plans, Inc. (WCG)
In the eyes of many of your peers, hedge funds are assumed to be delayed, old investment vehicles of a forgotten age.
Do Hedge Funds and Insiders Love Mylan Inc. (MYL)?
To many investors, hedge funds are assumed to be overrated, old financial vehicles of an era lost to time.
Hedge Funds Are Buying Amgen, Inc. (AMGN)
To the average investor, there are tons of metrics shareholders can use to analyze stocks. Some of the most innovative are hedge fund and insider trading activity.
This Biogen Idec Inc. (BIIB) Data is Screaming ‘Buy, Buy, Buy’
To many market players, hedge funds are assumed to be overrated, old investment vehicles of a forgotten age.
Is Illumina, Inc. (ILMN) Going to Burn These Hedge Funds?
If you were to ask many investors, hedge funds are assumed to be useless, old investment tools of a period lost to current times.
Is Celgene Corporation (CELG) Going to Burn You?
To many traders, hedge funds are perceived as overrated, outdated investment tools of a forgotten age.
Hedge Funds Are Buying Bristol Myers Squibb Co. (BMY)
In the eyes of many of your peers, hedge funds are perceived as useless, outdated financial tools of a forgotten age.
This Metric Says You Are Smart to Buy Merck & Co., Inc. (MRK)
Now, according to many investors, hedge funds are viewed as delayed, old investment tools of a period lost to current times.
Who’s Betting On Gilead Sciences, Inc. (GILD)?
If you were to ask many investors, hedge funds are seen as delayed, old financial vehicles of an era lost to time.
Accretive Health, Inc. (AH), Resolute Energy Corp (REN): Edward Gilhuly, Scott Stuart and Sageview Capital’s Favorite Buys
In 2006, Edward Gilhuly and Scott Stuart founded Sageview Capital, an investment firm that currently has about $800 million in assets under management.
Pernix Therapeutics Holdings Inc (PTX): Are Hedge Funds Right About This Stock?
In the financial world, there are plenty of gauges market participants can use to track their holdings.
Is Supernus Pharmaceuticals Inc (SUPN) Going to Burn These Hedge Funds?
To most shareholders, hedge funds are perceived as slow, outdated investment vehicles of yesteryear.
This Metric Says You Are Smart to Buy Curis, Inc. (CRIS)
Curis, Inc. (NASDAQ:CRIS) was in 10 hedge funds' portfolio at the end of March. CRIS investors should be aware of an increase in hedge fund interest in recent months.
XenoPort, Inc. (XNPT): Hedge Funds and Insiders Are Bearish, What Should You Do?
Is XenoPort, Inc. (NASDAQ:XNPT) a healthy stock for your portfolio? Money managers are in a pessimistic mood.
Hedge Funds Are Buying Solta Medical Inc (SLTM)
Is Solta Medical Inc (NASDAQ:SLTM) worth your attention right now? Investors who are in the know are getting more bullish.
Fluidigm Corporation (FLDM): Are Hedge Funds Right About This Stock?
Fluidigm Corporation (NASDAQ:FLDM) was in 6 hedge funds' portfolio at the end of March.
Antares Pharma Inc (ATRS): Hedge Funds Are Bullish and Insiders Are Bearish, What Should You Do?
In the eyes of most shareholders, hedge funds are perceived as worthless, old financial vehicles of the past.
